Lymphadenopathy: Difference between revisions

Jump to navigation Jump to search
Line 27: Line 27:
=Diagnostic Radiological Testing=
=Diagnostic Radiological Testing=


*'''Chest x-ray''': can reveal tuberculosis, pulmonary sarcoidosis, and pulmonary neoplasm.
*'''Chest CT scan''': This modality of radiological imaging can define the above processes and reveal hilar adenopathy.
*'''Abdominal and pelvic CT scan''': These images, in combination with chest CT scan, can be revealed in cases of supraclavicular adenopathy and the diagnosis of secondary neoplasm.
*'''Ultrasonography''': can be used in the assessment of number, size, size, shape, the marginal definition, and internal structures in patients with lymphadenopathy. Color Doppler ultrasonography is of use in distinguishing the vascular pattern between more established, pre-existing lymphadenopathy and acute lymphadenopathy. Studies have indicated that a low long axis to short axis ratio of lymphadenopathy as measured by ultrasound can be a significant indicator of lymphoma and metastatic cancer as a cause of lymphadenopathy.
*'''MRI scanning''': useful in the evaluation of thoracic, abdominal, and pelvic masses.
*'''PPD''': can be used in the diagnosis of tuberculosis
*'''Tissue diagnosis of the node''': this is done by incisional biopsy and remains the gold standard for diagnosis of lymphadenopathy.


==Treatment==
==Treatment==


Treatment of lymphadenopathy is based on the etiology. Generally, treatment of lymphadenopathy is as follows:
*Infectious causes of lymphadenopathy can be treated with antibiotic therapy, antiviral therapy, or antifungal therapy.
*Immune therapy, systemic glucocorticoids can be used for autoimmune causes of lymphadenopathy
*For malignancies, any combination of surgery, chemotherapy, and radiation therapy can be used.
*If medication is the suspected cause, discontinue the medication if possible.


==References==
==References==

Revision as of 17:46, 31 January 2021

Lymphadenopathy


Lymphadenopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphadenopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphadenopathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphadenopathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphadenopathy

CDC on Lymphadenopathy

Lymphadenopathy in the news

Blogs on Lymphadenopathy

Directions to Hospitals Treating Lymphadenopathy

Risk calculators and risk factors for Lymphadenopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Shyam Patel [2];Associate Editor(s)-in-Chief: Amandeep Singh M.D.[3], Raviteja Guddeti, M.B.B.S. [4] Ogechukwu Hannah Nnabude, MD


Synonyms and keywords: Lymph nodes enlarged; Enlarged lymph nodes; Lymphadenitis; Swollen lymph nodes; Swollen/enlarged lymph nodes
For patient information, click here

Overview

Classification

Pathophysiology

Histopathology

Causes

Differentiating Lymphadenopathy from other Diseases

Epidemiology and Demographics

Laboratory Evaluation of Lymphadenopathy

Diagnostic Radiological Testing

Treatment

References



Template:WikiDoc Sources